Williams Andrew Johns 4/A
4/A · Medicine Man Technologies, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4/AAmended
Williams Andrew Johns
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2018-06-20$1.62/sh−5,000$8,104→ 2,357,836 total(indirect: See Footnote) - Sale
Common Stock
2018-06-20$1.63/sh−5,000$8,162→ 2,352,836 total(indirect: See Footnote) - Sale
Common Stock
2018-06-22$1.59/sh−4,500$7,174→ 2,348,336 total(indirect: See Footnote) - Sale
Common Stock
2018-06-26$1.50/sh−7,500$11,271→ 2,334,236 total(indirect: See Footnote) - Sale
Common Stock
2018-06-20$1.62/sh−5,000$8,100→ 2,362,836 total(indirect: See Footnote) - Sale
Common Stock
2018-06-25$1.53/sh−6,600$10,128→ 2,341,736 total(indirect: See Footnote) - Sale
Common Stock
2018-06-26$1.54/sh−7,000$10,780→ 2,327,236 total(indirect: See Footnote) - Sale
Common Stock
2018-06-28$1.41/sh−7,000$9,870→ 2,318,602 total(indirect: See Footnote) - Sale
Common Stock
2018-06-28$1.44/sh−8,266$11,863→ 2,310,336 total(indirect: See Footnote) - Sale
Common Stock
2018-06-29$1.42/sh−6,830$9,699→ 2,303,506 total(indirect: See Footnote) - Sale
Common Stock
2018-06-18$1.63/sh−5,000$8,153→ 2,377,836 total(indirect: See Footnote) - Sale
Common Stock
2018-06-18$1.68/sh−10,000$16,817→ 2,367,836 total(indirect: See Footnote) - Sale
Common Stock
2018-06-27$1.55/sh−1,634$2,533→ 2,325,602 total(indirect: See Footnote)
Footnotes (1)
- [F1]Held in the name of the Andrew Johns Williams Revocable Trust Dated May 28, 2015.